IQVIA Holdings Inc. IQV is gaining from a massive addressable market, ... analytics-driven clinical development capabilities, ... Image Source: Zacks Investment ...

IQVIA Holdings reported strong Q1 earnings with $3.83B in revenue, ... PM Images. IQVIA Holdings (NYSE ... as it is one of the leading providers of advanced analytics, clinical research, ...

IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. 3 Things Investors Should Watch 1.

Durham, North Carolina-based IQVIA expects 2025 adjusted profit between $11.70 and $12.10 per share, where the midpoint is in line with analysts' average estimate of $11.90, according to data ...

IQVIA Holdings Inc. advanced stock charts by Barron's. View IQV historical stock data and compare to other stocks, and exchanges.

IQVIA Holdings Inc IQV reported Q3 sales of $3.74 billion, up 4.9% Y/Y on a reported basis and 4.1% at constant currency (CC), missing the consensus of $3.78 billion. IQVIA reported Q3 adjusted ...

RESEARCH TRIANGLE PARK, N.C., January 13, 2025--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights, and healthcare intelligence, today announced a ...

Contract research firm IQVIA Holdings raised its forecast for full-year profit on Monday, banking on strength in demand for its healthcare data and analytics services. Technological and analytical ...

Earnings per share were $1.97 on a GAAP diluted basis, with adjusted diluted earnings per share of $2.64. The company has now updated its guidance for the full year to be between $15.43 billion ...

IQVIA Holdings cut its full-year profit forecast on Wednesday, citing weakness in demand for its analytics and medical technology solutions along with the impact of a stronger U.S. dollar. Shares ...